Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Dima

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Critical Reviews in Clinical Laboratory Sciences|May 27, 2018
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approachesCiprian Tomuleasa, Cristina Selicean, Sonia Cismas, et al.
Critical Reviews in Clinical Laboratory Sciences|May 3, 2019
Transient leukemia of Down syndromeValentina Sas, Cristina Blag, Gabriela Zaharie, et al.
International Journal of Nanomedicine|March 2, 2016
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapyBobe Petrushev, Sanda Boca, Timea Simon, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 7, 2021
SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathyAndrei Stefancu, Vlad Moisoiu, Minodora Desmirean, et al.
Frontiers in Pharmacology|November 24, 2025
In-depth analysis for TKI-driven real-world management of 201 CML patients using TFRMihnea Lucian Micu, Simion Florin Cira, Mihnea Zdrenghea, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Journal of Cellular and Molecular Medicine|September 5, 2020
Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosisPatric Teodorescu, Sergiu Pasca, Ancuta Jurj, et al.
Journal of Cellular and Molecular Medicine|September 5, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemiaAdrian Bogdan Tigu, Catalin Sorin Constantinescu, Patric Teodorescu, et al.
Annals of Translational Medicine|August 23, 2021
Current therapeutic approaches in the management of hemophilia-a consensus view by the Romanian Society of HematologyIonut Hotea, Melen Brinza, Cristina Blag, et al.
Journal of Personalized Medicine|December 4, 2020
<i>TET2</i> rs1548483 SNP Associating with Susceptibility to Molecularly Annotated Polycythemia Vera and Primary MyelofibrosisDiana L Lighezan, Anca S Bojan, Mihaela Iancu, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Critical Reviews in Clinical Laboratory Sciences|May 27, 2018
Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approachesCiprian Tomuleasa, Cristina Selicean, Sonia Cismas, et al.
Critical Reviews in Clinical Laboratory Sciences|May 3, 2019
Transient leukemia of Down syndromeValentina Sas, Cristina Blag, Gabriela Zaharie, et al.
International Journal of Nanomedicine|March 2, 2016
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapyBobe Petrushev, Sanda Boca, Timea Simon, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 7, 2021
SERS-based DNA methylation profiling allows the differential diagnosis of malignant lymphadenopathyAndrei Stefancu, Vlad Moisoiu, Minodora Desmirean, et al.
Frontiers in Pharmacology|November 24, 2025
In-depth analysis for TKI-driven real-world management of 201 CML patients using TFRMihnea Lucian Micu, Simion Florin Cira, Mihnea Zdrenghea, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Journal of Cellular and Molecular Medicine|September 5, 2020
Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosisPatric Teodorescu, Sergiu Pasca, Ancuta Jurj, et al.
Journal of Cellular and Molecular Medicine|September 5, 2023
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemiaAdrian Bogdan Tigu, Catalin Sorin Constantinescu, Patric Teodorescu, et al.
Annals of Translational Medicine|August 23, 2021
Current therapeutic approaches in the management of hemophilia-a consensus view by the Romanian Society of HematologyIonut Hotea, Melen Brinza, Cristina Blag, et al.
Journal of Personalized Medicine|December 4, 2020
<i>TET2</i> rs1548483 SNP Associating with Susceptibility to Molecularly Annotated Polycythemia Vera and Primary MyelofibrosisDiana L Lighezan, Anca S Bojan, Mihaela Iancu, et al.
Pageof 11